Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Neurofibrosarcoma, also known as peripheral nerve sheath tumor, is a malignant tumor that develops in the cells surrounding the peripheral nerves.
How Dana-Farber/Boston Children’s Cancer and Blood Disorders Center approaches neurofibrosarcoma
We understand that you may have a lot of questions when your child is diagnosed with neurofibrosarcoma. Is it dangerous? Will it affect my child long-term? What do we do next? We’ve tried to provide some answers to those questions in the following pages, and our experts can explain your child’s condition fully. If you have further questions during your hospital stay, we have a resource room that will help answer your questions.
Our multidisciplinary Bone and Soft Tissue Program team conducts in-depth discussions of each case and personalizes treatment plans for every patient. Your child will receive integrated care from a team that includes the following specialists:
In addition, our cancer center offers the following services:
A weekly survivorship clinic, which set the national standard for childhood cancer survivorship care. This weekly clinic offers ongoing care to manage late effects caused by your child’s cancer or the treatment they received.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”